First-line Antihypertensive Treatment in Patients with Pre-Diabetes
Author Information
Author(s): Zidek Walter, Schrader Joachim, Lüders Stephan, Matthaei Stephan, Hasslacher Christoph, Hoyer Joachim, Bramlage Peter, Sturm Claus-Dieter, Paar W Dieter
Primary Institution: Medical Department IV, University Hospital Charité, Campus Benjamin-Franklin, Berlin, Germany
Hypothesis
Does an ACE inhibitor-based treatment reduce the incidence of type 2 diabetes compared to a diuretic-based treatment in patients with pre-diabetes?
Conclusion
The ADaPT study aims to provide valuable data on the effects of antihypertensive treatments on diabetes development in high-risk patients.
Supporting Evidence
- Patients in the study were at high risk for diabetes development.
- The average age of participants was 67.1 years.
- 56.5% of participants had dyslipidemia.
- 37.8% reported a family history of diabetes.
- 57.8% had a previous diagnosis of hypertension.
Takeaway
This study is looking at how different blood pressure medications can help people who are at risk of getting diabetes.
Methodology
A 4-year open, prospective, parallel group phase IV study comparing ramipril versus diuretics or beta-blockers in patients with pre-diabetes.
Potential Biases
Patients may receive 'unallowed' medications during the study, affecting comparability.
Limitations
The study is observational and not randomized, which may introduce bias.
Participant Demographics
Average age of 67.1 years, 47% male, with a BMI of 29.9 kg/m2.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website